153 related articles for article (PubMed ID: 29260604)
1. The role of mental health and addiction among high-cost patients: a population-based study.
de Oliveira C; Cheng J; Rehm J; Kurdyak P
J Med Econ; 2018 Apr; 21(4):348-355. PubMed ID: 29260604
[TBL] [Abstract][Full Text] [Related]
2. Patients With High Mental Health Costs Incur Over 30 Percent More Costs Than Other High-Cost Patients.
de Oliveira C; Cheng J; Vigod S; Rehm J; Kurdyak P
Health Aff (Millwood); 2016 Jan; 35(1):36-43. PubMed ID: 26733699
[TBL] [Abstract][Full Text] [Related]
3. Unique Characteristics of High-Cost Users of Medical Care With Comorbid Mental Illness or Addiction in a Population-Based Cohort.
Hensel JM; Taylor VH; Fung K; de Oliveira C; Vigod SN
Psychosomatics; 2018; 59(2):135-143. PubMed ID: 29157683
[TBL] [Abstract][Full Text] [Related]
4. Understanding healthcare burden and treatment patterns among young adults with schizophrenia.
Huang A; Amos TB; Joshi K; Wang L; Nash A
J Med Econ; 2018 Oct; 21(10):1026-1035. PubMed ID: 30001651
[TBL] [Abstract][Full Text] [Related]
5. The effect of socio-demographic factors on mental health and addiction high-cost use: a retrospective, population-based study in Saskatchewan.
Anderson M; Revie CW; Quail JM; Wodchis W; de Oliveira C; Osman M; Baetz M; McClure J; Stryhn H; Buckeridge D; Neudorf C
Can J Public Health; 2018 Dec; 109(5-6):810-820. PubMed ID: 29981109
[TBL] [Abstract][Full Text] [Related]
6. The Economic Burden of Chronic Psychotic Disorders in Ontario.
de Oliveira C; Cheng J; Rehm J; Kurdyak P
J Ment Health Policy Econ; 2016 Dec; 19(4):181-192. PubMed ID: 27991417
[TBL] [Abstract][Full Text] [Related]
7. Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
Bonafede M; Richhariya A; Cai Q; Josephson NC; McMorrow D; Garfin PM; Perales MA
J Med Econ; 2017 Dec; 20(12):1244-1251. PubMed ID: 28782449
[TBL] [Abstract][Full Text] [Related]
8. Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population.
Rice JB; White AG; Johnson M; Wagh A; Qin Y; Bartels-Peculis L; Ciepielewska G; Nelson WW
J Med Econ; 2018 Sep; 21(9):846-852. PubMed ID: 29741439
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of sarcoidosis in a commercially-insured population in the United States.
Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
[TBL] [Abstract][Full Text] [Related]
10. Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population.
Wang SX; Ganguli AX; Bodhani A; Medema JK; Reichmann WM; Macaulay D
J Med Econ; 2017 Dec; 20(12):1299-1306. PubMed ID: 28880733
[TBL] [Abstract][Full Text] [Related]
11. The burden of multiple sclerosis in Japan.
Nohara C; Hase M; Liebert R; Wu N
J Med Econ; 2017 Dec; 20(12):1290-1298. PubMed ID: 28849983
[TBL] [Abstract][Full Text] [Related]
12. Predicting high-cost privately insured patients based on self-reported health and utilization data.
Cunningham PJ
Am J Manag Care; 2017 Jul; 23(7):e215-e222. PubMed ID: 28850789
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
Al Sawah S; Foster SA; Goldblum OM; Malatestinic WN; Zhu B; Shi N; Song X; Feldman SR
J Med Econ; 2017 Sep; 20(9):982-990. PubMed ID: 28635342
[TBL] [Abstract][Full Text] [Related]
14. Universal Drug Coverage and Socioeconomic Disparities in Health Care Costs Among Persons With Diabetes.
Isaranuwatchai W; Fazli GS; Bierman AS; Lipscombe LL; Mitsakakis N; Shah BR; Wu CF; Johns A; Booth GL
Diabetes Care; 2020 Sep; 43(9):2098-2105. PubMed ID: 32641377
[TBL] [Abstract][Full Text] [Related]
15. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
16. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
17. A 3-year study of high-cost users of health care.
Wodchis WP; Austin PC; Henry DA
CMAJ; 2016 Feb; 188(3):182-188. PubMed ID: 26755672
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with mental illness and persistent high-cost status: a population-based analysis.
de Oliveira C; Mason J; Kurdyak P
CMAJ; 2020 Dec; 192(50):E1793-E1801. PubMed ID: 33318090
[TBL] [Abstract][Full Text] [Related]
19. Rates of Mental Illness and Addiction among High-Cost Users of Medical Services in Ontario.
Hensel JM; Taylor VH; Fung K; Vigod SN
Can J Psychiatry; 2016 Jun; 61(6):358-66. PubMed ID: 27254845
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
